UA104822C2 - Способ, соединение, фармацевтическая композиция и лекарственное средство для восстановления утраченной памяти в норме и патологии - Google Patents
Способ, соединение, фармацевтическая композиция и лекарственное средство для восстановления утраченной памяти в норме и патологииInfo
- Publication number
- UA104822C2 UA104822C2 UAA201303657A UAA201303657A UA104822C2 UA 104822 C2 UA104822 C2 UA 104822C2 UA A201303657 A UAA201303657 A UA A201303657A UA A201303657 A UAA201303657 A UA A201303657A UA 104822 C2 UA104822 C2 UA 104822C2
- Authority
- UA
- Ukraine
- Prior art keywords
- pharmaceutical composition
- nitrogen
- general formula
- compounds
- body weight
- Prior art date
Links
- 150000001875 compounds Chemical class 0.000 title abstract 3
- 239000008194 pharmaceutical composition Substances 0.000 title abstract 2
- 230000032683 aging Effects 0.000 title 1
- 230000001575 pathological effect Effects 0.000 title 1
- IJGRMHOSHXDMSA-UHFFFAOYSA-N nitrogen Substances N#N IJGRMHOSHXDMSA-UHFFFAOYSA-N 0.000 abstract 3
- 230000037396 body weight Effects 0.000 abstract 2
- 229910052757 nitrogen Inorganic materials 0.000 abstract 2
- 125000001997 phenyl group Chemical group [H]C1=C([H])C([H])=C(*)C([H])=C1[H] 0.000 abstract 2
- 229920006395 saturated elastomer Polymers 0.000 abstract 2
- NINIDFKCEFEMDL-UHFFFAOYSA-N Sulfur Chemical group [S] NINIDFKCEFEMDL-UHFFFAOYSA-N 0.000 abstract 1
- 239000005864 Sulphur Chemical group 0.000 abstract 1
- 230000002411 adverse Effects 0.000 abstract 1
- 125000005907 alkyl ester group Chemical group 0.000 abstract 1
- 125000000217 alkyl group Chemical group 0.000 abstract 1
- 150000001408 amides Chemical class 0.000 abstract 1
- 125000003118 aryl group Chemical group 0.000 abstract 1
- 125000004429 atom Chemical group 0.000 abstract 1
- QVGXLLKOCUKJST-UHFFFAOYSA-N atomic oxygen Chemical group [O] QVGXLLKOCUKJST-UHFFFAOYSA-N 0.000 abstract 1
- 201000010099 disease Diseases 0.000 abstract 1
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 abstract 1
- 239000003814 drug Substances 0.000 abstract 1
- 229940079593 drug Drugs 0.000 abstract 1
- 125000001072 heteroaryl group Chemical group 0.000 abstract 1
- 125000005842 heteroatom Chemical group 0.000 abstract 1
- QJGQUHMNIGDVPM-UHFFFAOYSA-N nitrogen group Chemical group [N] QJGQUHMNIGDVPM-UHFFFAOYSA-N 0.000 abstract 1
- 230000003287 optical effect Effects 0.000 abstract 1
- 239000001301 oxygen Chemical group 0.000 abstract 1
- 229910052760 oxygen Inorganic materials 0.000 abstract 1
- 150000003839 salts Chemical class 0.000 abstract 1
- 230000001225 therapeutic effect Effects 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D407/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having oxygen atoms as the only ring hetero atoms, not provided for by group C07D405/00
- C07D407/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having oxygen atoms as the only ring hetero atoms, not provided for by group C07D405/00 containing two hetero rings
- C07D407/12—Heterocyclic compounds containing two or more hetero rings, at least one ring having oxygen atoms as the only ring hetero atoms, not provided for by group C07D405/00 containing two hetero rings linked by a chain containing hetero atoms as chain links
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
- C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
- C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D213/24—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with substituted hydrocarbon radicals attached to ring carbon atoms
- C07D213/36—Radicals substituted by singly-bound nitrogen atoms
- C07D213/40—Acylated substituent nitrogen atom
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
- C07D401/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a chain containing hetero atoms as chain links
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D407/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having oxygen atoms as the only ring hetero atoms, not provided for by group C07D405/00
- C07D407/14—Heterocyclic compounds containing two or more hetero rings, at least one ring having oxygen atoms as the only ring hetero atoms, not provided for by group C07D405/00 containing three or more hetero rings
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Biomedical Technology (AREA)
- Neurology (AREA)
- Neurosurgery (AREA)
- General Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Psychiatry (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Hospice & Palliative Care (AREA)
- Pharmacology & Pharmacy (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Pyridine Compounds (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| RU2010137094/04A RU2457205C2 (ru) | 2010-09-07 | 2010-09-07 | Способ, соединение и фармацевтическая композиция и лекарственное средство для восстановления утраченной памяти в норме и патологии |
| PCT/RU2011/000677 WO2012033435A1 (ru) | 2010-09-07 | 2011-09-06 | Способ, соединение, фармацевтическая композиция и лекарственное средство для восстановления утраченной памяти в норме и патологии |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| UA104822C2 true UA104822C2 (ru) | 2014-03-11 |
Family
ID=45810868
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| UAA201303657A UA104822C2 (ru) | 2010-09-07 | 2011-09-06 | Способ, соединение, фармацевтическая композиция и лекарственное средство для восстановления утраченной памяти в норме и патологии |
Country Status (4)
| Country | Link |
|---|---|
| EA (1) | EA028534B1 (ru) |
| RU (1) | RU2457205C2 (ru) |
| UA (1) | UA104822C2 (ru) |
| WO (1) | WO2012033435A1 (ru) |
Families Citing this family (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| RU2016146594A (ru) * | 2016-11-28 | 2018-05-28 | Общество С Ограниченной Ответственностью "Биофарм-Меморейн" | Средство для лечения деменции различной этиологии |
Family Cites Families (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| TW449590B (en) * | 1995-04-14 | 2001-08-11 | Boehringer Ingelheim Kg | New arylglycinamide derivatives, processes for the manufacture thereof and pharmaceutical compositions containing these compounds |
| RU2364587C2 (ru) * | 2003-10-29 | 2009-08-20 | Элан Фармасьютикалз, Инк. | N-замещенные бензолсульфонамиды |
| MX2010008021A (es) * | 2008-01-29 | 2010-08-04 | Hoffmann La Roche | Nuevos derivados de n-(2-amino-fenil)-amida. |
-
2010
- 2010-09-07 RU RU2010137094/04A patent/RU2457205C2/ru active IP Right Revival
-
2011
- 2011-09-06 EA EA201370026A patent/EA028534B1/ru not_active IP Right Cessation
- 2011-09-06 WO PCT/RU2011/000677 patent/WO2012033435A1/ru not_active Ceased
- 2011-09-06 UA UAA201303657A patent/UA104822C2/ru unknown
Also Published As
| Publication number | Publication date |
|---|---|
| RU2010137094A (ru) | 2012-04-20 |
| EA028534B1 (ru) | 2017-11-30 |
| RU2457205C2 (ru) | 2012-07-27 |
| EA201370026A1 (ru) | 2013-07-30 |
| WO2012033435A1 (ru) | 2012-03-15 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| BR112012027640A2 (pt) | composto, composição farmacêutica uso de um composto, e, métodos de preparar uma composição farmacêutica, de inibir a função da 11beta-hidroxiesteroide desidrogenase do tipo 1 e de tratamento ou prevenção de um distúrbio | |
| UA107112C2 (uk) | Активатори розчинної гуанілатциклази | |
| BR112012009215A2 (pt) | "terapia combinada contra o cancer com compostos inibidores de hsp90" | |
| UA109698C2 (xx) | Похідні азаіндазолу або діазаіндазолу як медикамент | |
| EA201100305A1 (ru) | Лечение респираторных заболеваний | |
| ITBO20110012A1 (it) | Composizioni farmaceutiche comprendenti rifaximina e loro uso. | |
| EA201070588A1 (ru) | Производные 1,2,3-триазола для применения в качестве ингибиторов стеароил-соа десатуразы | |
| WO2008125600A3 (en) | Pyrazole derivatives as p2x7 modulators | |
| WO2009066041A3 (fr) | Derives de 1,2,4,5-tetrahydro-3h-benzazepines, leur procede de preparation et les compositions pharmaceutiques qui les contiennent | |
| NZ587202A (en) | Methods for measuring a patient response upon administration of a drug and compositions thereof | |
| UA109421C2 (uk) | Фармацевтична композиція, яка містить ліганди сигма-рецептора | |
| BR112013017302A2 (pt) | formulações de imunossupressor | |
| BR112013026257A2 (pt) | derivados de glicosídeo e usos dos mesmos para o tratamento de diabetes | |
| AR076300A1 (es) | Derivados de pirimidin imidazoles sustituidos, inhibidores de gsk3, composiciones farmaceuticas que los contienen y usos de los mismos en el tratamiento del alzheimer, enfermedades neurodegenerativas agudas, diabetes y otras enfermedades. | |
| CO6361855A2 (es) | Derivados de 7-hidroxi-benzoimidazol-4-il-,etanona e inhibidores de cinasa que enlaza pdz que contienen los mismos | |
| UA101407C2 (ru) | Стабильная комбинированная фармацевтическая композиция амлодипина и бисопролола фумарат | |
| TW200626158A (en) | Naphthaline derivatives | |
| MX2009006114A (es) | Composiciones que comprenden carisoprodol y metodos de uso de las mismas. | |
| UA97348C2 (en) | HETEROCYCLIC NF-kB INHIBITORS | |
| BR112012022632A2 (pt) | Medicamento compreendendo agonista de ep4 | |
| CO6612211A2 (es) | Derivado de amida que tiene una acción hipoglucémica y/o una acción protectora de células b o pancreas | |
| UA104822C2 (ru) | Способ, соединение, фармацевтическая композиция и лекарственное средство для восстановления утраченной памяти в норме и патологии | |
| US20150191430A1 (en) | Conjugates of huperzine and analogs thereof | |
| MA32719B1 (fr) | Formulations galeniques de composes organiques | |
| MX2012012410A (es) | Agente terapeutico y agente preventivo para enfermedad de alzheimer. |